NYSEAMERICAN:DXR Daxor (DXR) Stock Price, News & Analysis $9.07 +0.08 (+0.83%) As of 06/20/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Daxor Stock (NYSEAMERICAN:DXR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Daxor alerts:Sign Up Key Stats Today's Range$9.11▼$9.3850-Day Range$7.20▼$9.2952-Week Range$6.55▼$10.00Volume4,637 shsAverage Volume8,739 shsMarket Capitalization$43.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.Read More… Receive DXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Daxor and its competitors with MarketBeat's FREE daily newsletter. Email Address DXR Stock News HeadlinesDaxor expands blood volume analysis technology across three networksMarch 28, 2025 | markets.businessinsider.comDaxor expands BVA services at Midwest healthcare facilityFebruary 28, 2025 | markets.businessinsider.comRevealed: Steve Jobs' Secret Project Comes to Life on July 21st?Did Steve Jobs Leave Behind a $25 Trillion Gift for America? In his final years, America's greatest innovator worked on a secretive project beyond Apple's walls— a vision he believed would transform our nation's economy and restore its global leadership. Insiders called it "extraordinary" and "a model for improving America." On July 21st, this hidden legacy could finally be revealed, unlocking what CNBC calls a "$25 trillion opportunity" for generations to come.June 22, 2025 | InvestorPlace (Ad)Daxor announces case series published in JACCFebruary 14, 2025 | markets.businessinsider.comDaxor stock hits 52-week low at $6.83 amid market challengesFebruary 11, 2025 | msn.comDaxor expands ezBVA Lab service to two new hospital systemsDecember 19, 2024 | markets.businessinsider.comDAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24October 9, 2024 | finance.yahoo.comNewly Published Review Highlights the Pivotal Role of Daxor's Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome ManagementSeptember 12, 2024 | stockhouse.comSee More Headlines DXR Stock Analysis - Frequently Asked Questions How have DXR shares performed this year? Daxor's stock was trading at $7.9350 at the start of the year. Since then, DXR shares have increased by 14.4% and is now trading at $9.0750. View the best growth stocks for 2025 here. How do I buy shares of Daxor? Shares of DXR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Daxor own? Based on aggregate information from My MarketBeat watchlists, some other companies that Daxor investors own include Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD), Novavax (NVAX), iBio (IBIO), CRISPR Therapeutics (CRSP) and Dynavax Technologies (DVAX). Company Calendar Today6/21/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Instruments & Supplies Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:DXR Previous SymbolNYSE:DXR CIK27367 Webwww.daxor.com Phone(865) 425-0555Fax212-244-0806Employees37Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,740,000Free Float1,866,000Market Cap$43.02 million OptionableNot Optionable Beta-0.50 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free Report This page (NYSEAMERICAN:DXR) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredYour Guide to Outperforming the Market - Guaranteed.Join the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.